世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 トランスクリプトームシーケンス - 世界市場シェアとランキング、全体売上高と需要予測 2025-2031Transcriptome Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 トランスクリプトームシーケンスの世界市場規模は、2024年に25億7,111万米ドルと推定され、2025年から2031年の予測期間中のCAGRは14.17%で、2031年には60億7,262万米ドルに再調整されると予測されています。 ト... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリートランスクリプトームシーケンスの世界市場規模は、2024年に25億7,111万米ドルと推定され、2025年から2031年の予測期間中のCAGRは14.17%で、2031年には60億7,262万米ドルに再調整されると予測されています。トランスクリプトームシーケンスの北米市場は、2024年に10億3,543万ドルと評価され、2025年から2031年の予測期間中に14.1％のCAGRで、2031年までに24億2,930万ドルに達すると予測されます。 トランスクリプトームシーケンスのアジア太平洋市場は、2024年に6億7,421万ドルと評価され、2025年から2031年の予測期間中に15.42％のCAGRで、2031年までに17億2,486万ドルに達する見込みです。 トランスクリプトームシーケンスの欧州市場は、2024年に8億213万ドルと評価され、2025年から2031年の予測期間中に13.4％のCAGRで、2031年までに18億727万ドルに達するだろう。 トランスクリプトームシーケンスの世界の主要企業には、Illumina、Thermo Fisher Scientific、Eurofins Scientific、Roche、Bio-Rad、Agilent Technologies、LabCorp、QIAGEN、Pacific Biosciences、Azenta、BGI Genomics、Novogene、Macrogen、Shanghai ZJ Bio-Tech、Tsingke Biotechnologyなどがある。2024年には、世界の大手5社が収益ベースで約66.47%のシェアを占める。 本レポートは、トランスクリプトームシーケンスの世界市場について、地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングを中心に包括的に紹介することを目的としています。 トランスクリプトームシーケンス市場規模、推計、予測は、2024年を基準年とし、2020年から2031年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量的および定性的な分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、トランスクリプトームシーケンスに関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 イルミナ サーモフィッシャーサイエンティフィック ユーロフィンズ・サイエンティフィック ロシュ バイオ・ラッド アジレント・テクノロジー ラボコープ QIAGEN パシフィックバイオサイエンス アゼンタ BGIジェノミクス ノボジーン マクロゲン 上海ZJバイオテック 清科生物技術 タイプ別セグメント コーディングRNA ノンコーディングRNA 用途別セグメント バイオメディカル分野 非医療分野 地域別 北米 米国 カナダ メキシコ アジア太平洋 中国 日本 韓国 東南アジア インド その他のアジア太平洋地域 欧州 ドイツ フランス 英国 イタリア 北欧諸国 その他のヨーロッパ 南米 ブラジル その他の南米諸国 中東・アフリカ 各章の概要 第1章： レポートのスコープ、世界の総市場規模を紹介します。本章ではまた、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：トランスクリプトームシーケンス企業の競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章：様々な市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展の可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第4章：用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる下流市場でブルーオーシャン市場を見つけるのを助ける。 第5章：地域レベルでのトランスクリプトームシーケンスの収益。各地域の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展見込み、市場スペース、市場規模を紹介しています。 第6章：国レベルでのトランスクリプトームシーケンスの収益。各国／地域のタイプ別、用途別のシグメイトデータを提供しています。 第7章：主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview 11.1 Transcriptome Sequencing Product Introduction 1 1.2 Global Transcriptome Sequencing Market Size Forecast (2020-2031) 1 1.3 Transcriptome Sequencing Market Trends & Drivers 3 1.3.1 Transcriptome Sequencing Industry Trends 3 1.3.2 Transcriptome Sequencing Market Drivers & Opportunity 4 1.3.3 Transcriptome Sequencing Market Challenges 5 1.4 Assumptions and Limitations 5 1.5 Study Objectives 6 1.6 Years Considered 7 2 Competitive Analysis by Company 8 2.1 Global Transcriptome Sequencing Players Revenue Ranking (2024) 8 2.2 Global Transcriptome Sequencing Revenue by Company (2020-2025) 9 2.3 Key Companies Transcriptome Sequencing Manufacturing Base Distribution and Headquarters 11 2.4 Transcriptome Sequencing Market Competitive Analysis 12 2.4.1 Transcriptome Sequencing Market Concentration Rate (2020-2025) 12 2.4.2 Global 5 and 10 Largest Companies by Transcriptome Sequencing Revenue in 2024 13 2.4.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024) 14 2.5 Mergers & Acquisitions, Expansion 16 3 Segmentation by Type 17 3.1 Introduction by Type 17 3.1.1 Coding RNA 17 3.1.2 Noncoding RNA 17 3.2 Global Transcriptome Sequencing Sales Value by Type 18 3.2.1 Global Transcriptome Sequencing Sales Value by Type (2020 VS 2024 VS 2031) 18 3.2.2 Global Transcriptome Sequencing Sales Value, by Type (2020-2031) 20 3.2.3 Global Transcriptome Sequencing Sales Value, by Type (%) (2020-2031) 20 4 Segmentation by Application 22 4.1 Introduction by Application 22 4.1.1 Biomedical Field 22 4.1.2 Non-medical Field 22 4.2 Global Transcriptome Sequencing Sales Value by Application 23 4.2.1 Global Transcriptome Sequencing Sales Value by Application (2020 VS 2024 VS 2031) 23 4.2.2 Global Transcriptome Sequencing Sales Value, by Application (2020-2031) 25 4.2.3 Global Transcriptome Sequencing Sales Value, by Application (%) (2020-2031) 25 5 Segmentation by Region 27 5.1 Global Transcriptome Sequencing Sales Value by Region 27 5.1.1 Global Transcriptome Sequencing Sales Value by Region: 2020 VS 2024 VS 2031 27 5.1.2 Global Transcriptome Sequencing Sales Value by Region (2020-2025) 27 5.1.3 Global Transcriptome Sequencing Sales Value by Region (2026-2031) 28 5.1.4 Global Transcriptome Sequencing Sales Value by Region (%), (2020-2031) 28 5.2 North America 30 5.2.1 North America Transcriptome Sequencing Sales Value, 2020-2031 30 5.2.2 North America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 31 5.3 Europe 32 5.3.1 Europe Transcriptome Sequencing Sales Value, 2020-2031 32 5.3.2 Europe Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 33 5.4 Asia Pacific 34 5.4.1 Asia Pacific Transcriptome Sequencing Sales Value, 2020-2031 34 5.4.2 Asia Pacific Transcriptome Sequencing Sales Value by Region (%), 2024 VS 2031 35 5.5 South America 36 5.5.1 South America Transcriptome Sequencing Sales Value, 2020-2031 36 5.5.2 South America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 37 5.6 Middle East & Africa 38 5.6.1 Middle East & Africa Transcriptome Sequencing Sales Value, 2020-2031 38 5.6.2 Middle East & Africa Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 39 6 Segmentation by Key Countries/Regions 40 6.1 Key Countries/Regions Transcriptome Sequencing Sales Value Growth Trends, 2020 VS 2024 VS 2031 40 6.2 Key Countries/Regions Transcriptome Sequencing Sales Value, 2020-2031 41 6.3 United States 44 6.3.1 United States Transcriptome Sequencing Sales Value, 2020-2031 44 6.3.2 United States Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 45 6.3.3 United States Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 46 6.4 Europe 47 6.4.1 Europe Transcriptome Sequencing Sales Value, 2020-2031 47 6.4.2 Europe Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 48 6.4.3 Europe Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 49 6.5 China 50 6.5.1 China Transcriptome Sequencing Sales Value, 2020-2031 50 6.5.2 China Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 51 6.5.3 China Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 52 6.6 Japan 53 6.6.1 Japan Transcriptome Sequencing Sales Value, 2020-2031 53 6.6.2 Japan Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 54 6.6.3 Japan Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 55 6.7 South Korea 56 6.7.1 South Korea Transcriptome Sequencing Sales Value, 2020-2031 56 6.7.2 South Korea Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 57 6.7.3 South Korea Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 58 6.8 Southeast Asia 59 6.8.1 Southeast Asia Transcriptome Sequencing Sales Value, 2020-2031 59 6.8.2 Southeast Asia Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 60 6.8.3 Southeast Asia Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 61 6.9 India 62 6.9.1 India Transcriptome Sequencing Sales Value, 2020-2031 62 6.9.2 India Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 63 6.9.3 India Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 64 7 Company Profiles 65 7.1 Illumina 65 7.1.1 Illumina Profile 65 7.1.2 Illumina Main Business 66 7.1.3 Illumina Transcriptome Sequencing Products, Services and Solutions 66 7.1.4 Illumina Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 67 7.1.5 Illumina Recent Developments 67 7.2 Thermo Fisher Scientific 68 7.2.1 Thermo Fisher Scientific Profile 68 7.2.2 Thermo Fisher Scientific Main Business 68 7.2.3 Thermo Fisher Scientific Transcriptome Sequencing Products, Services and Solutions 69 7.2.4 Thermo Fisher Scientific Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 69 7.2.5 Thermo Fisher Scientific Recent Developments 70 7.3 Eurofins Scientific 70 7.3.1 Eurofins Scientific Profile 70 7.3.2 Eurofins Scientific Main Business 71 7.3.3 Eurofins Scientific Transcriptome Sequencing Products, Services and Solutions 71 7.3.4 Eurofins Scientific Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 73 7.3.5 Eurofins Scientific Recent Developments 73 7.4 Roche 73 7.4.1 Roche Profile 73 7.4.2 Roche Main Business 74 7.4.3 Roche Transcriptome Sequencing Products, Services and Solutions 74 7.4.4 Roche Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 75 7.4.5 Roche Recent Developments 75 7.5 Bio-Rad 76 7.5.1 Bio-Rad Profile 76 7.5.2 Bio-Rad Main Business 76 7.5.3 Bio-Rad Transcriptome Sequencing Products, Services and Solutions 77 7.5.4 Bio-Rad Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 78 7.5.5 Bio-Rad Recent Developments 78 7.6 Agilent Technologies 78 7.6.1 Agilent Technologies Profile 79 7.6.2 Agilent Technologies Main Business 79 7.6.3 Agilent Technologies Transcriptome Sequencing Products, Services and Solutions 80 7.6.4 Agilent Technologies Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 80 7.6.5 Agilent Technologies Recent Developments 81 7.7 LabCorp 81 7.7.1 LabCorp Profile 81 7.7.2 LabCorp Main Business 82 7.7.3 LabCorp Transcriptome Sequencing Products, Services and Solutions 82 7.7.4 LabCorp Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 84 7.7.5 LabCorp Recent Developments 84 7.8 QIAGEN 84 7.8.1 QIAGEN Profile 84 7.8.2 QIAGEN Main Business 85 7.8.3 QIAGEN Transcriptome Sequencing Products, Services and Solutions 85 7.8.4 QIAGEN Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 87 7.8.5 QIAGEN Recent Developments 87 7.9 Pacific Biosciences 87 7.9.1 Pacific Biosciences Profile 87 7.9.2 Pacific Biosciences Main Business 88 7.9.3 Pacific Biosciences Transcriptome Sequencing Products, Services and Solutions 88 7.9.4 Pacific Biosciences Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 89 7.9.5 Pacific Biosciences Recent Developments 89 7.10 Azenta 89 7.10.1 Azenta Profile 90 7.10.2 Azenta Main Business 90 7.10.3 Azenta Transcriptome Sequencing Products, Services and Solutions 91 7.10.4 Azenta Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 91 7.10.5 Azenta Recent Developments 92 7.11 BGI Genomics 92 7.11.1 BGI Genomics Profile 92 7.11.2 BGI Genomics Main Business 93 7.11.3 BGI Genomics Transcriptome Sequencing Products, Services and Solutions 93 7.11.4 BGI Genomics Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 94 7.11.5 BGI Genomics Recent Developments 94 7.12 Novogene 94 7.12.1 Novogene Profile 95 7.12.2 Novogene Main Business 95 7.12.3 Novogene Transcriptome Sequencing Products, Services and Solutions 96 7.12.4 Novogene Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 97 7.12.5 Novogene Recent Developments 97 7.13 Macrogen 97 7.13.1 Macrogen Profile 97 7.13.2 Macrogen Main Business 98 7.13.3 Macrogen Transcriptome Sequencing Products, Services and Solutions 98 7.13.4 Macrogen Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 99 7.13.5 Macrogen Recent Developments 100 7.14 Shanghai ZJ Bio-Tech 100 7.14.1 Shanghai ZJ Bio-Tech Profile 100 7.14.2 Shanghai ZJ Bio-Tech Main Business 101 7.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Products, Services and Solutions 101 7.14.4 Shanghai ZJ Bio-Tech Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 102 7.14.5 Shanghai ZJ Bio-Tech Recent Developments 102 7.15 Tsingke Biotechnology 102 7.15.1 Tsingke Biotechnology Profile 103 7.15.2 Tsingke Biotechnology Main Business 103 7.15.3 Tsingke Biotechnology Transcriptome Sequencing Products, Services and Solutions 104 7.15.4 Tsingke Biotechnology Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 104 7.15.5 Tsingke Biotechnology Recent Developments 104 8 Industry Chain Analysis 105 8.1 Transcriptome Sequencing Industrial Chain 105 8.2 Transcriptome Sequencing Upstream Analysis 105 8.2.1 Key Raw Materials 105 8.2.2 Manufacturing Cost Structure 106 8.3 Analysis Pipeline 107 8.4 Downstream Analysis (Customers Analysis) 108 8.5 Sales Model and Sales Channels 109 9 Research Findings and Conclusion 110 10 Appendix 111 10.1 Research Methodology 111 10.1.1 Methodology/Research Approach 111 10.1.2 Data Source 114 10.2 Author Details 117 10.3 Disclaimer 118
SummaryThe global market for Transcriptome Sequencing was estimated to be worth US$ 2,571.11 million in 2024 and is forecast to a readjusted size of US$ 6,072.62 million by 2031 with a CAGR of 14.17% during the forecast period 2025-2031. Table of Contents1 Market Overview 11.1 Transcriptome Sequencing Product Introduction 1 1.2 Global Transcriptome Sequencing Market Size Forecast (2020-2031) 1 1.3 Transcriptome Sequencing Market Trends & Drivers 3 1.3.1 Transcriptome Sequencing Industry Trends 3 1.3.2 Transcriptome Sequencing Market Drivers & Opportunity 4 1.3.3 Transcriptome Sequencing Market Challenges 5 1.4 Assumptions and Limitations 5 1.5 Study Objectives 6 1.6 Years Considered 7 2 Competitive Analysis by Company 8 2.1 Global Transcriptome Sequencing Players Revenue Ranking (2024) 8 2.2 Global Transcriptome Sequencing Revenue by Company (2020-2025) 9 2.3 Key Companies Transcriptome Sequencing Manufacturing Base Distribution and Headquarters 11 2.4 Transcriptome Sequencing Market Competitive Analysis 12 2.4.1 Transcriptome Sequencing Market Concentration Rate (2020-2025) 12 2.4.2 Global 5 and 10 Largest Companies by Transcriptome Sequencing Revenue in 2024 13 2.4.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024) 14 2.5 Mergers & Acquisitions, Expansion 16 3 Segmentation by Type 17 3.1 Introduction by Type 17 3.1.1 Coding RNA 17 3.1.2 Noncoding RNA 17 3.2 Global Transcriptome Sequencing Sales Value by Type 18 3.2.1 Global Transcriptome Sequencing Sales Value by Type (2020 VS 2024 VS 2031) 18 3.2.2 Global Transcriptome Sequencing Sales Value, by Type (2020-2031) 20 3.2.3 Global Transcriptome Sequencing Sales Value, by Type (%) (2020-2031) 20 4 Segmentation by Application 22 4.1 Introduction by Application 22 4.1.1 Biomedical Field 22 4.1.2 Non-medical Field 22 4.2 Global Transcriptome Sequencing Sales Value by Application 23 4.2.1 Global Transcriptome Sequencing Sales Value by Application (2020 VS 2024 VS 2031) 23 4.2.2 Global Transcriptome Sequencing Sales Value, by Application (2020-2031) 25 4.2.3 Global Transcriptome Sequencing Sales Value, by Application (%) (2020-2031) 25 5 Segmentation by Region 27 5.1 Global Transcriptome Sequencing Sales Value by Region 27 5.1.1 Global Transcriptome Sequencing Sales Value by Region: 2020 VS 2024 VS 2031 27 5.1.2 Global Transcriptome Sequencing Sales Value by Region (2020-2025) 27 5.1.3 Global Transcriptome Sequencing Sales Value by Region (2026-2031) 28 5.1.4 Global Transcriptome Sequencing Sales Value by Region (%), (2020-2031) 28 5.2 North America 30 5.2.1 North America Transcriptome Sequencing Sales Value, 2020-2031 30 5.2.2 North America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 31 5.3 Europe 32 5.3.1 Europe Transcriptome Sequencing Sales Value, 2020-2031 32 5.3.2 Europe Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 33 5.4 Asia Pacific 34 5.4.1 Asia Pacific Transcriptome Sequencing Sales Value, 2020-2031 34 5.4.2 Asia Pacific Transcriptome Sequencing Sales Value by Region (%), 2024 VS 2031 35 5.5 South America 36 5.5.1 South America Transcriptome Sequencing Sales Value, 2020-2031 36 5.5.2 South America Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 37 5.6 Middle East & Africa 38 5.6.1 Middle East & Africa Transcriptome Sequencing Sales Value, 2020-2031 38 5.6.2 Middle East & Africa Transcriptome Sequencing Sales Value by Country (%), 2024 VS 2031 39 6 Segmentation by Key Countries/Regions 40 6.1 Key Countries/Regions Transcriptome Sequencing Sales Value Growth Trends, 2020 VS 2024 VS 2031 40 6.2 Key Countries/Regions Transcriptome Sequencing Sales Value, 2020-2031 41 6.3 United States 44 6.3.1 United States Transcriptome Sequencing Sales Value, 2020-2031 44 6.3.2 United States Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 45 6.3.3 United States Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 46 6.4 Europe 47 6.4.1 Europe Transcriptome Sequencing Sales Value, 2020-2031 47 6.4.2 Europe Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 48 6.4.3 Europe Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 49 6.5 China 50 6.5.1 China Transcriptome Sequencing Sales Value, 2020-2031 50 6.5.2 China Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 51 6.5.3 China Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 52 6.6 Japan 53 6.6.1 Japan Transcriptome Sequencing Sales Value, 2020-2031 53 6.6.2 Japan Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 54 6.6.3 Japan Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 55 6.7 South Korea 56 6.7.1 South Korea Transcriptome Sequencing Sales Value, 2020-2031 56 6.7.2 South Korea Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 57 6.7.3 South Korea Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 58 6.8 Southeast Asia 59 6.8.1 Southeast Asia Transcriptome Sequencing Sales Value, 2020-2031 59 6.8.2 Southeast Asia Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 60 6.8.3 Southeast Asia Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 61 6.9 India 62 6.9.1 India Transcriptome Sequencing Sales Value, 2020-2031 62 6.9.2 India Transcriptome Sequencing Sales Value by Type (%), 2024 VS 2031 63 6.9.3 India Transcriptome Sequencing Sales Value by Application, 2024 VS 2031 64 7 Company Profiles 65 7.1 Illumina 65 7.1.1 Illumina Profile 65 7.1.2 Illumina Main Business 66 7.1.3 Illumina Transcriptome Sequencing Products, Services and Solutions 66 7.1.4 Illumina Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 67 7.1.5 Illumina Recent Developments 67 7.2 Thermo Fisher Scientific 68 7.2.1 Thermo Fisher Scientific Profile 68 7.2.2 Thermo Fisher Scientific Main Business 68 7.2.3 Thermo Fisher Scientific Transcriptome Sequencing Products, Services and Solutions 69 7.2.4 Thermo Fisher Scientific Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 69 7.2.5 Thermo Fisher Scientific Recent Developments 70 7.3 Eurofins Scientific 70 7.3.1 Eurofins Scientific Profile 70 7.3.2 Eurofins Scientific Main Business 71 7.3.3 Eurofins Scientific Transcriptome Sequencing Products, Services and Solutions 71 7.3.4 Eurofins Scientific Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 73 7.3.5 Eurofins Scientific Recent Developments 73 7.4 Roche 73 7.4.1 Roche Profile 73 7.4.2 Roche Main Business 74 7.4.3 Roche Transcriptome Sequencing Products, Services and Solutions 74 7.4.4 Roche Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 75 7.4.5 Roche Recent Developments 75 7.5 Bio-Rad 76 7.5.1 Bio-Rad Profile 76 7.5.2 Bio-Rad Main Business 76 7.5.3 Bio-Rad Transcriptome Sequencing Products, Services and Solutions 77 7.5.4 Bio-Rad Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 78 7.5.5 Bio-Rad Recent Developments 78 7.6 Agilent Technologies 78 7.6.1 Agilent Technologies Profile 79 7.6.2 Agilent Technologies Main Business 79 7.6.3 Agilent Technologies Transcriptome Sequencing Products, Services and Solutions 80 7.6.4 Agilent Technologies Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 80 7.6.5 Agilent Technologies Recent Developments 81 7.7 LabCorp 81 7.7.1 LabCorp Profile 81 7.7.2 LabCorp Main Business 82 7.7.3 LabCorp Transcriptome Sequencing Products, Services and Solutions 82 7.7.4 LabCorp Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 84 7.7.5 LabCorp Recent Developments 84 7.8 QIAGEN 84 7.8.1 QIAGEN Profile 84 7.8.2 QIAGEN Main Business 85 7.8.3 QIAGEN Transcriptome Sequencing Products, Services and Solutions 85 7.8.4 QIAGEN Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 87 7.8.5 QIAGEN Recent Developments 87 7.9 Pacific Biosciences 87 7.9.1 Pacific Biosciences Profile 87 7.9.2 Pacific Biosciences Main Business 88 7.9.3 Pacific Biosciences Transcriptome Sequencing Products, Services and Solutions 88 7.9.4 Pacific Biosciences Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 89 7.9.5 Pacific Biosciences Recent Developments 89 7.10 Azenta 89 7.10.1 Azenta Profile 90 7.10.2 Azenta Main Business 90 7.10.3 Azenta Transcriptome Sequencing Products, Services and Solutions 91 7.10.4 Azenta Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 91 7.10.5 Azenta Recent Developments 92 7.11 BGI Genomics 92 7.11.1 BGI Genomics Profile 92 7.11.2 BGI Genomics Main Business 93 7.11.3 BGI Genomics Transcriptome Sequencing Products, Services and Solutions 93 7.11.4 BGI Genomics Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 94 7.11.5 BGI Genomics Recent Developments 94 7.12 Novogene 94 7.12.1 Novogene Profile 95 7.12.2 Novogene Main Business 95 7.12.3 Novogene Transcriptome Sequencing Products, Services and Solutions 96 7.12.4 Novogene Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 97 7.12.5 Novogene Recent Developments 97 7.13 Macrogen 97 7.13.1 Macrogen Profile 97 7.13.2 Macrogen Main Business 98 7.13.3 Macrogen Transcriptome Sequencing Products, Services and Solutions 98 7.13.4 Macrogen Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 99 7.13.5 Macrogen Recent Developments 100 7.14 Shanghai ZJ Bio-Tech 100 7.14.1 Shanghai ZJ Bio-Tech Profile 100 7.14.2 Shanghai ZJ Bio-Tech Main Business 101 7.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Products, Services and Solutions 101 7.14.4 Shanghai ZJ Bio-Tech Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 102 7.14.5 Shanghai ZJ Bio-Tech Recent Developments 102 7.15 Tsingke Biotechnology 102 7.15.1 Tsingke Biotechnology Profile 103 7.15.2 Tsingke Biotechnology Main Business 103 7.15.3 Tsingke Biotechnology Transcriptome Sequencing Products, Services and Solutions 104 7.15.4 Tsingke Biotechnology Transcriptome Sequencing Revenue (US$ Million) & (2020-2025) 104 7.15.5 Tsingke Biotechnology Recent Developments 104 8 Industry Chain Analysis 105 8.1 Transcriptome Sequencing Industrial Chain 105 8.2 Transcriptome Sequencing Upstream Analysis 105 8.2.1 Key Raw Materials 105 8.2.2 Manufacturing Cost Structure 106 8.3 Analysis Pipeline 107 8.4 Downstream Analysis (Customers Analysis) 108 8.5 Sales Model and Sales Channels 109 9 Research Findings and Conclusion 110 10 Appendix 111 10.1 Research Methodology 111 10.1.1 Methodology/Research Approach 111 10.1.2 Data Source 114 10.2 Author Details 117 10.3 Disclaimer 118
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
